Rob Fagan is a researcher at Canada’s GMP Securities. He first started working there in 2011 as a research associate for a consumer products analyst. Rob has an eye on cannabis chains in the US, where he watches the stocks of companies like Curaleaf Holdings and Green Thumb Industries.